BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15195107)

  • 1. Nasal-type extranodal natural killer/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore.
    Ng SB; Lai KW; Murugaya S; Lee KM; Loong SL; Fook-Chong S; Tao M; Sng I
    Mod Pathol; 2004 Sep; 17(9):1097-107. PubMed ID: 15195107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among Koreans.
    Ko YH; Ree HJ; Kim WS; Choi WH; Moon WS; Kim SW
    Cancer; 2000 Nov; 89(10):2106-16. PubMed ID: 11066052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease.
    Quintanilla-Martinez L; Kremer M; Keller G; Nathrath M; Gamboa-Dominguez A; Meneses A; Luna-Contreras L; Cabras A; Hoefler H; Mohar A; Fend F
    Am J Pathol; 2001 Dec; 159(6):2095-105. PubMed ID: 11733360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
    Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
    Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: high prevalence of p53 overexpression.
    Quintanilla-Martinez L; Franklin JL; Guerrero I; Krenacs L; Naresh KN; Rama-Rao C; Bhatia K; Raffeld M; Magrath IT
    Hum Pathol; 1999 Jul; 30(7):849-55. PubMed ID: 10414505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations.
    Petit B; Leroy K; Kanavaros P; Boulland ML; Druet-Cabanac M; Haioun C; Bordessoule D; Gaulard P
    Hum Pathol; 2001 Feb; 32(2):196-204. PubMed ID: 11230707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
    Chan JK; Sin VC; Wong KF; Ng CS; Tsang WY; Chan CH; Cheung MM; Lau WH
    Blood; 1997 Jun; 89(12):4501-13. PubMed ID: 9192774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathology, immunophenotype, T cell receptor gene rearrangement, Epstein-Barr virus status and p53 gene mutation of cutaneous extranodal NK/T-cell lymphoma, nasal-type.
    Wang TT; Xu C; Liu SL; Kan B; Ran YP; Liu WP; Li GD; Wang L
    Chin Med J (Engl); 2013 Apr; 126(7):1281-7. PubMed ID: 23557559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of the pathology, immunophenotype, etiology and genetic marker of NK/T-cell lymphoma].
    Zhong BN; Zhang XH; Li M; Cao HG; Li N; Liu CY; Gu YQ; Gao ZF
    Zhonghua Xue Ye Xue Za Zhi; 2003 Oct; 24(10):505-9. PubMed ID: 14690577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas.
    Tsang WY; Chan JK; Yip TT; Ng CS; Wong KF; Poon YF; Ma VW
    Hum Pathol; 1994 Aug; 25(8):758-65. PubMed ID: 7520016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage.
    Chiang AK; Chan AC; Srivastava G; Ho FC
    Int J Cancer; 1997 Nov; 73(3):332-8. PubMed ID: 9359478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extranodal natural killer/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors.
    Jhuang JY; Chang ST; Weng SF; Pan ST; Chu PY; Hsieh PP; Wei CH; Chou SC; Koo CL; Chen CJ; Hsu JD; Chuang SS
    Hum Pathol; 2015 Feb; 46(2):313-21. PubMed ID: 25554090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cyclin-dependent kinase 6 (cdk6) and frequent loss of CD44 in nasal-nasopharyngeal NK/T-cell lymphomas: comparison with CD56-negative peripheral T-cell lymphomas.
    Lien HC; Lin CW; Huang PH; Chang ML; Hsu SM
    Lab Invest; 2000 Jun; 80(6):893-900. PubMed ID: 10879740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus infection, drug resistance and prognosis in Korean T- and NK-cell lymphomas.
    Jung CK; Lee KY; Kim Y; Han K; Shim SI; Kim BK; Kang CS
    Pathol Int; 2001 May; 51(5):355-63. PubMed ID: 11422793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus.
    Kanavaros P; Lescs MC; Brière J; Divine M; Galateau F; Joab I; Bosq J; Farcet JP; Reyes F; Gaulard P
    Blood; 1993 May; 81(10):2688-95. PubMed ID: 8387835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T- and T/natural killer-cell lymphomas of the salivary gland: a clinicopathologic, immunohistochemical and molecular study of six cases.
    Chan JK; Tsang WY; Hui PK; Ng CS; Sin VC; Khan SM; Siu LL
    Hum Pathol; 1997 Feb; 28(2):238-45. PubMed ID: 9023409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotypic and genotypic characterization of nasal lymphoma with polymorphic reticulosis morphology.
    Ohsawa M; Nakatsuka S; Kanno H; Miwa H; Kojya S; Harabuchi Y; Yang WI; Aozasa K
    Int J Cancer; 1999 Jun; 81(6):865-70. PubMed ID: 10362131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
    Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
    Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasopharyngeal/nasal type T/NK lymphomas: analysis of 14 cases and review of the literature.
    García-Cosío M; Santón A; Méndez MC; Rivas C; Martín C; Bellas C
    Tumori; 2003; 89(3):278-84. PubMed ID: 12908783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metalloproteinase (MMP-1, 2 and 11), tissue inhibitor of metalloproteinase-1 (TIMP-1), and p53 expression in nasal-type angiocentric T/NK-cell lymphoma: an immunohistochemical study].
    Meneses-García A; Herrera J; Mohar A; García-Cuellar C; Súchil-Bernal L
    Gac Med Mex; 2005; 141(4):291-6. PubMed ID: 16164124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.